Viral vector manufacturer ViroCell Biologics is leasing its first-ever facility — located at Great Ormond Street Hospital in London — so it can offer its services for clinical research.

ViroCell worked with the hospital for about 18 months to secure the GMP certificate for the London facility, which was granted in January this year, CEO John Hadden told Endpoints News in an interview. The viral vector license was granted two weeks ago.

Click the link in the title to read more

News from Disruptive capital GP Limited